Filed before 2025Filed 1 August 2018
Gossamer Bio, Inc. raised $230M
Gossamer Bio, Inc., a biotech company based in San Diego, CA, raised $230M in a new equity round, according to a filing dated 1 August 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 1 August 2018
- Round
- Equity round
- Amount sold
- $230M
- Offering size
- $230M
- Investors so far
- 67
- Based in
- San Diego, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 99% of the 1,729 tracked raises with an amount filed in 2018, and than 98% of the 160 in biotech.
Gossamer Bio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Sep 2026 | New filing | $25M | Not tracked |
| 1 Aug 2018 | New filing | $230M | This raise |
| 19 Jan 2018 | New filing | $70.5M | Another raise |
| 19 Jan 2018 | New filing | $70.5M | Another raise |
More with Cure Ventures on the board
- Tasca Therapeutics Corp$48.1M
- Crosslink Therapeutics Inc.$4.25M
- Alessa Therapeutics, Inc.$25.4M
- Deep 6 AI Inc.$26.9M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.